翰宇藥業(300199.SZ):子公司防護和醫用口罩產品獲歐盟CE認證
格隆匯3月20日丨翰宇藥業(300199.SZ)公佈,近日,公司全資子公司甘肅成紀生物藥業有限公司(“成紀藥業”)收到ICR(International Certification Registrar)的通知,成紀藥業的防護和醫用口罩產品獲得了歐盟CE認證。產品名稱:Protective Mask(防護口罩)和Medical Mask(醫用口罩)。
隨着新冠肺炎在全球的蔓延,口罩作為醫用和民用防護用品之一,國際市場對相關產品的需求日益增大。此次成紀藥業生產的口罩產品獲得歐盟CE認證,表明相關產品取得了海外銷售資質,有利於進一步增強公司及子公司的國際綜合競爭力。近期公司也陸續接到來自北美、歐盟以及東南亞多個地區客户的詢單,公司正積極推動口罩產品在海外市場的銷售,努力為公司帶來新的盈利增長點。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.